VPRAX Mutual Fund

NAV$25.60

Fund Essentials - as of Dec 31, 2025

Net Assets
$693M
Expense Ratio
0.65%
Dividend Yield (Current)
16.80%
Holdings
277
Inception Date
May 3, 2016
Fund Family
Voya Investment Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Semi-Annually

Performance

YTD+5.42%
1 Year+11.33%
3 Year+12.15%
5 Year+8.31%
10 Year+11.21%

Asset Allocation

Stocks: 61.50%
Bonds: 32.64%
Other: 5.85%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
MSFTMicrosoft Corp 4.100 Feb 06 374.58%
NVDANvidia Corp4.36%
AAPLApple Inc3.96%
GOOGAlphabet Inc series C3.85%
AMZNAmazon.Com Inc3.63%
Top 10 Concentration: 36.32%Report Date: Dec 31, 2025
Download all 277 holdings for VPRAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
16.80%
Frequency
Semi-Annually
Latest Distribution
$0.31
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how VPRAX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

VPRAX Mutual Fund Overview

VPRAX Mutual Fund (VY T. Rowe Price Capital Appreciation Portfolio Class R6) is managed by Voya Investment Management with $693.1M in net assets. VPRAX expense ratio is 0.65%, holding 277 positions across sectors including Information Technology, Other, Unknown. Inception date: 2016-05-03.

VPRAX performance shows a YTD return of 5.42%. The 1-year return is 11.33% and the 5-year return is 8.31%. VPRAX dividend yield stands at 16.80%, paid semi-annually.

VPRAX top holdings include Microsoft Corp 4.100 Feb 06 37 (4.6%), Nvidia Corp (4.4%), Apple Inc (4.0%), Alphabet Inc series C (3.9%), Amazon.Com Inc (3.6%). View all VPRAX holdings, sector breakdown, or dividend history.

VPRAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. VPRAX alternatives are available via the screener, along with tax-loss harvesting opportunities.